Patent Yard Sign in
Expired Canadian patentCanada

N-1-(3-benzoylpropyl)-4-piperidyl-sulfonic acid amides and processes for production thereof

CA 1097648 A · Owner: Boehringer Ingelheim G.M.B.H. · Inventors: Weber, Karl-Heinz; Boke, Karin; Langbein, Adolf

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates to novel N-1-(3-benzoylpropyl3- 4-piperidyl-sulphonic acid amides having interesting pharmacological properties. In particular the novel, compounds exhibit an adrenalin antagonistic effect in the absence of amphetamine and apomorphine antagonistic activities, in addition the novel compounds lack or only exhibit weak cataleptic properties and thus may have useful antipyschotic properties with only a very slight effect on the extrapyramidal motor system. Processes for the preparation of the novel compounds are described and exemplified and examples of pharmaceutical compositions containing them are given.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted March 17, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 17, 1998.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 25, 1978
GrantedMarch 17, 1981
Term endedMarch 17, 1998
Patent numberCA 1097648 A
Classification (IPC)C07D211/58 +1 more

Timeline

Timeline From CIPO dates

1979198119831985198719891991199319951997Application filedApril 25, 1978Patent grantedMarch 17, 1981Term endedMarch 17, 1998

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.